Sign In

Login

Password

Forgot Password ? Sign Up

Vortexkeratopathie (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Vortexkeratopathie" in German language version.

refsWebsite
Global rank German rank
11nih.gov
4th place
7th place
8doi.org
2nd place
3rd place
1akdae.de
low place
1,853rd place
1zdb-katalog.de
123rd place
6th place
1dog2009.org
low place
low place

akdae.de

  • Caprelsa® (Vandetanib). (PDF; 141 kB) Information der Arzneimittelkommission der deutschen Ärzteschaft (AkdÄ), Stand: 12. Juni 2012.

dog2009.org

doi.org

  • A. P. Burlina, K. B. Sims u. a.: Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel. In: BMC neurology, 2011, Band 11, S. 61; doi:10.1186/1471-2377-11-61. PMID 21619592. PMC 3126707 (freier Volltext).
  • D. P. Germain: Fabry disease. In: Orphanet Journal of Rare Diseases, 2010, Band 5, S. 30; doi:10.1186/1750-1172-5-30. PMID 21092187. PMC 3009617 (freier Volltext). (Review im Open Access).
  • K. Falke, A. Büttner u. a.: The microstructure of cornea verticillata in Fabry disease and amiodarone-induced keratopathy: a confocal laser-scanning microscopy study. In: Graefe’s archive for clinical and experimental ophthalmology, April 2009, Band 247, Nummer 4, S. 523–534, doi:10.1007/s00417-008-0962-9. PMID 18931853.
  • S. Yeh, H. A. Fine, J. A. Smith: Corneal verticillata after dual anti-epidermal growth factor receptor and anti-vascular endothelial growth factor receptor 2 therapy (vandetanib) for anaplastic astrocytoma. In: Cornea, Juli 2009, Band 28, Nummer 6, S. 699–702, doi:10.1097/ICO.0b013e3181922146. PMID 19512898.
  • Sean S. Rivera, Nicole Radunzel, Erin A. Boese: Symptomatic Netarsudil-Induced Verticillata. In: JAMA ophthalmology. Band 141, Nr. 11, 1. November 2023, ISSN 2168-6173, S. e232949, doi:10.1001/jamaophthalmol.2023.2949, PMID 37971506.
  • T. T. Nguyen, T. Gin u. a.: Ophthalmological manifestations of Fabry disease: a survey of patients at the Royal Melbourne Fabry Disease Treatment Centre. In: Clinical & experimental ophthalmology, April 2005, Band 33, Nummer 2, S. 164–168, doi:10.1111/j.1442-9071.2005.00990.x. PMID 15807825.
  • A. Sodi, A. S. Ioannidis u. a.: Ocular manifestations of Fabry’s disease: data from the Fabry Outcome Survey. In: The British journal of ophthalmology, Februar 2007, Band 91, Nummer 2, S. 210–214; doi:10.1136/bjo.2006.100602. PMID 16973664. PMC 1857640 (freier Volltext).
  • J. Wasielica-Poslednik, N. Pfeiffer u. a.: Confocal laser-scanning microscopy allows differentiation between Fabry disease and amiodarone-induced keratopathy. In: Graefe’s archive for clinical and experimental ophthalmology, [elektronische Veröffentlichung vor dem Druck] Juli 2011; doi:10.1007/s00417-011-1726-5. PMID 21720814.

nih.gov

ncbi.nlm.nih.gov

  • A. P. Burlina, K. B. Sims u. a.: Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel. In: BMC neurology, 2011, Band 11, S. 61; doi:10.1186/1471-2377-11-61. PMID 21619592. PMC 3126707 (freier Volltext).
  • D. P. Germain: Fabry disease. In: Orphanet Journal of Rare Diseases, 2010, Band 5, S. 30; doi:10.1186/1750-1172-5-30. PMID 21092187. PMC 3009617 (freier Volltext). (Review im Open Access).
  • K. Falke, A. Büttner u. a.: The microstructure of cornea verticillata in Fabry disease and amiodarone-induced keratopathy: a confocal laser-scanning microscopy study. In: Graefe’s archive for clinical and experimental ophthalmology, April 2009, Band 247, Nummer 4, S. 523–534, doi:10.1007/s00417-008-0962-9. PMID 18931853.
  • E. Chew, M. Ghosh, C. McCulloch: Amiodarone-induced cornea verticillata. In: Canadian journal of ophthalmology. Journal canadien d’ophtalmologie, Juni 1982, Band 17, Nummer 3, S. 96–99, PMID 7116220.
  • K. U. Seiler, H. J. Thiel, O. Wassermann: Die Chloroquinkeratopathie als Beispiel einer arzneimittelinduzierten Phospholipidosis (zugleich ein Beitrag zur Pathogenese der Cornea verticillata). In: Klinische Monatsblätter für Augenheilkunde, Januar 1977, Band 170, Nummer 1, S. 64–73, PMID 15159.
  • S. Yeh, H. A. Fine, J. A. Smith: Corneal verticillata after dual anti-epidermal growth factor receptor and anti-vascular endothelial growth factor receptor 2 therapy (vandetanib) for anaplastic astrocytoma. In: Cornea, Juli 2009, Band 28, Nummer 6, S. 699–702, doi:10.1097/ICO.0b013e3181922146. PMID 19512898.
  • Sean S. Rivera, Nicole Radunzel, Erin A. Boese: Symptomatic Netarsudil-Induced Verticillata. In: JAMA ophthalmology. Band 141, Nr. 11, 1. November 2023, ISSN 2168-6173, S. e232949, doi:10.1001/jamaophthalmol.2023.2949, PMID 37971506.
  • C. Orssaud, J. Dufier, D. Germain: Ocular manifestations in Fabry disease: a survey of 32 hemizygous male patients. In: Ophthalmic genetics, September 2003, Band 24, Nummer 3, S. 129–139; PMID 12868031.
  • T. T. Nguyen, T. Gin u. a.: Ophthalmological manifestations of Fabry disease: a survey of patients at the Royal Melbourne Fabry Disease Treatment Centre. In: Clinical & experimental ophthalmology, April 2005, Band 33, Nummer 2, S. 164–168, doi:10.1111/j.1442-9071.2005.00990.x. PMID 15807825.
  • A. Sodi, A. S. Ioannidis u. a.: Ocular manifestations of Fabry’s disease: data from the Fabry Outcome Survey. In: The British journal of ophthalmology, Februar 2007, Band 91, Nummer 2, S. 210–214; doi:10.1136/bjo.2006.100602. PMID 16973664. PMC 1857640 (freier Volltext).
  • J. Wasielica-Poslednik, N. Pfeiffer u. a.: Confocal laser-scanning microscopy allows differentiation between Fabry disease and amiodarone-induced keratopathy. In: Graefe’s archive for clinical and experimental ophthalmology, [elektronische Veröffentlichung vor dem Druck] Juli 2011; doi:10.1007/s00417-011-1726-5. PMID 21720814.

zdb-katalog.de